Selective Detection of Hydrazine in the Presence of Excess Electrochemically Active Pharmaceutical Ingredients Using Boron Doped Diamond Metal Nanoparticle Functionalised Electrodes |
| |
Authors: | Anthony W. T. Bristow Andrew D. Ray Julie V. Macpherson |
| |
Affiliation: | 1. Pharmaceutical Development, AstraZeneca, Macclesfield, SK10 2NA, UK;2. Department of Chemistry, University of Warwick, Coventry, CV4 7AL, UK |
| |
Abstract: | Detection of the genotoxic impurity hydrazine (HZ) in the presence of active pharmaceutical ingredients (APIs) represents a significant challenge to the pharmaceutical industry. Here we show how the use of electrochemical strategies in conjunction with metal nanoparticle (NP) functionalised polycrystalline boron‐doped diamond (BDD) electrodes enables detection of HZ in the presence of two different electrochemically active APIs. By simply changing the chemical identity of the metal NP, which shifts the detection potential for HZ, it is possible to selectively screen out the API signature from the HZ current – voltage response. HZ detection limits of 11.1 µM (Au NP BDD) and 3.3 µM (Pt NP BDD) in the presence of excess acetaminophen and promazine respectively, were determined using differential pulse voltammetry in quiescent solution. |
| |
Keywords: | Nanoparticles Electroanalysis Boron doped diamond Hydrazine Active pharmaceutical ingredient |
|
|